Muscle Invasive Bladder Carcinoma — Trials

Muscle Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 34
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03775265	Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer	active not recruiting	Phase 3	475	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT05776758	Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt	active not recruiting	Phase 3	236	Regina Elena Cancer InstituteOTHER	1	Aug 17, 2026	clinicaltrials